
The long-awaited conclusion of the blockbuster Carlos Correa/Mets deal was pending for the Christmas holidays on Sunday. But it seems that there are still reasons to have a good dose of hope.
It was said that the Mets and Correa camp were trying to smooth things over Since the team mentioned a problem with Correa’s physical exam, which was played Thursday and Friday in New York. The heist, which was learned on Saturday, is believed to relate to an ankle operation carried out in 2014 and a subsequent MRI.
Before the holidays momentarily intervened, the parties were discussing the value of a questionable MRI versus the “functionality” of the joint and Correa’s reliability history – he only missed an average than 14 games over the past three seasons, and according to agent Scott Boras has never received related treatment since that 2014 operation.
The sides seemed excited and motivated to do this business when it was agreed, and with the Mets and Correa camp saying they were “working things out” on Saturday, there seemed to be some optimism that things could be worked out. The Mets realized that the Giants doctor discovered this problem when the Mets and Correa’s camp agreed to the 12-year, $315 million deal in the middle of the night that shook New York.
Word is that a few more teams have checked in following the Mets’ findings. But unlike the case of the Giants, where they only informed the Correa camp that they needed more time according to what Boras told the New York writers on Thursday, there appear to be more in-depth discussions between the Mets and Correa’s representatives after this last medical examination.


There was a lot of excitement about the deal following Mets owner Steve Cohen’s deal with Boras around 8:30 p.m. Tuesday in Hawaii (2:30 a.m. PT), where Cohen was vacationing. (Boras was on the phone from San Francisco, where Correa’s press conference had been canceled hours earlier.)
“We needed one more thing, and that’s it,” Cohen told the Post moments after the deal was closed. It was important. … It puts us above.
Correa would also be thrilled for the chance to join that star-studded Mets team, which now has a record slate of over $380 million and a good shot at being the World Series favorite (if that deal happens). Correa has been said to be fine giving up the shortstop position even though he is considered one of the best two or three defensive shortstops in the game, if not the best, to move to third base and accommodate his friend Francisco Lindor.

Much of the discussion following the Mets medical review seems tied to the value of relying on an MRI versus actual on-field performance and reliability. But ultimately, the parties may have to agree on language to protect the Mets, at least. It’s unclear if Correa is motivated enough to agree to any kind of reshuffling of the terms, or even if the Mets will suggest anything along those lines.
In the past, Boras has sometimes addressed medical issues with revised contract language, as he did in the case of JD Martinez, whose past foot issues were pointed out during a Red Sox review at the following an agreement on his five-year, $110 million contract with Boston.
“There are no current issues with Carlos’ health,” Boras told the New York Writers Thursday while in town for Carlos Rodon’s Yankees press conference. The Mets, however, seem to be worried about his future.
0 Comments